BRPI0607684A2 - composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida - Google Patents
composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamidaInfo
- Publication number
- BRPI0607684A2 BRPI0607684A2 BRPI0607684-0A BRPI0607684A BRPI0607684A2 BR PI0607684 A2 BRPI0607684 A2 BR PI0607684A2 BR PI0607684 A BRPI0607684 A BR PI0607684A BR PI0607684 A2 BRPI0607684 A2 BR PI0607684A2
- Authority
- BR
- Brazil
- Prior art keywords
- indene
- furan
- propionamide
- tetrahydro
- ethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
COMPOSIçãO FARMACêUTICA, METODO PARA PREVENIR OU TRATAR DISTúRBIOS DE DEPRESSãO OU ANSIEDADE, E, USO DE (S)-N-[2-( 1 ,6,7,8-TETRAIDRO-2H-INDENO[5,4-B]FURAN-8-IL)-ETIL]-PROPI ONAMIDA. A presente invenção proporciona um agente profilático ou farmacêutico para distúrbios de depressão ou ansiedade, compreendendo (5)- N- [2-( 1 ,6,7,8-tetraidro-2H-indeno [5 ,4-b] furan-8-il)-etil] -propionamida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005107674 | 2005-04-04 | ||
PCT/JP2006/307047 WO2006107019A1 (ja) | 2005-04-04 | 2006-04-03 | うつ病または不安神経症の予防または治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0607684A2 true BRPI0607684A2 (pt) | 2009-09-22 |
Family
ID=37073564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0607684-0A BRPI0607684A2 (pt) | 2005-04-04 | 2006-04-03 | composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida |
Country Status (23)
Country | Link |
---|---|
US (1) | US20090042861A1 (pt) |
EP (1) | EP1867641A4 (pt) |
JP (1) | JP5259181B2 (pt) |
KR (1) | KR20070118103A (pt) |
CN (1) | CN101189219A (pt) |
AR (1) | AR054435A1 (pt) |
AU (1) | AU2006231752B2 (pt) |
BR (1) | BRPI0607684A2 (pt) |
CA (1) | CA2602267A1 (pt) |
CL (1) | CL2009000980A1 (pt) |
CR (1) | CR9385A (pt) |
GE (1) | GEP20105001B (pt) |
IL (1) | IL186049A0 (pt) |
MA (1) | MA29677B1 (pt) |
MY (1) | MY142214A (pt) |
NO (1) | NO20075599L (pt) |
NZ (1) | NZ561677A (pt) |
PE (1) | PE20061355A1 (pt) |
RU (1) | RU2413510C2 (pt) |
TW (1) | TWI391132B (pt) |
UA (1) | UA89397C2 (pt) |
WO (1) | WO2006107019A1 (pt) |
ZA (1) | ZA200708445B (pt) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018176109A1 (pt) | 2017-03-30 | 2018-10-04 | Penello Temporao Jose Eduardo | Composição mulivítamínica para aprimoramento da fluência verbal, dimimuição dos sintomas da ansiedade de performance e seu método de preparação |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2248808B1 (en) * | 2008-01-31 | 2014-07-16 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder |
US8426461B2 (en) | 2011-01-17 | 2013-04-23 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
EP2665465A1 (en) * | 2011-01-17 | 2013-11-27 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
EP2765985A1 (en) * | 2011-10-14 | 2014-08-20 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
CN102718675B (zh) * | 2012-06-07 | 2015-03-25 | 上海右手医药科技开发有限公司 | 阿戈美拉汀甲磺酸复合物及其制备方法 |
RU2571546C1 (ru) * | 2014-07-14 | 2015-12-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежский государственный медицинский университет имени Н.Н. Бурденко" Министерства здравоохранения Российской Федерации | Способ дифференцированной диагностики и терапии синдрома ночной еды |
CN108451917A (zh) * | 2018-03-22 | 2018-08-28 | 仁和堂药业有限公司 | 高稳定性米安色林制剂的制备方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4241013A1 (de) * | 1992-12-05 | 1994-06-09 | Boehringer Ingelheim Kg | Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung |
CZ286081B6 (cs) * | 1994-06-10 | 2000-01-12 | Smithkline Beecham P. L. C. | Benzopyrany a jejich použití jako terapeutických činidel |
US5780470A (en) * | 1995-06-02 | 1998-07-14 | Bristol-Myers Squibb Company | Melatonergic indanyl piperazines |
DK0885210T5 (da) * | 1996-03-08 | 2008-10-13 | Takeda Pharmaceutical | Tricykliske forbindelser med bindingsaffinitet for melatoninreceptorer, deres fremstilling og anvendelse |
US6034239A (en) | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
JP2884153B2 (ja) * | 1996-03-08 | 1999-04-19 | 武田薬品工業株式会社 | 三環性化合物、その製造法および剤 |
JP3509637B2 (ja) * | 1998-06-09 | 2004-03-22 | 武田薬品工業株式会社 | 睡眠障害予防治療剤 |
ATE247967T1 (de) * | 1998-06-09 | 2003-09-15 | Takeda Chemical Industries Ltd | Pharmazeutische kombination mit einem trizyclischen komponent und mindestens einem aus zolpidem, zopiclone und brotizolam, zur behandlung von schlafstörungen |
HUP0301719A2 (hu) * | 2000-06-27 | 2003-09-29 | Taisho Pharmaceutical Co., Ltd. | Szorongásos neurózis vagy depresszió kezelésére szolgáló gyógyszerkészítmény és piperazinszármazékok |
US6589978B2 (en) * | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
US6569887B2 (en) * | 2001-08-24 | 2003-05-27 | Dov Pharmaceuticals Inc. | (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake |
CA2459304A1 (en) * | 2001-09-13 | 2003-03-20 | Schering Corporation | Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic |
US20070088079A1 (en) * | 2005-09-20 | 2007-04-19 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for sleep disorder |
-
2006
- 2006-04-03 MY MYPI20061491A patent/MY142214A/en unknown
- 2006-04-03 CA CA002602267A patent/CA2602267A1/en not_active Abandoned
- 2006-04-03 US US11/918,034 patent/US20090042861A1/en not_active Abandoned
- 2006-04-03 CN CNA2006800197795A patent/CN101189219A/zh active Pending
- 2006-04-03 EP EP06730995A patent/EP1867641A4/en not_active Withdrawn
- 2006-04-03 BR BRPI0607684-0A patent/BRPI0607684A2/pt not_active IP Right Cessation
- 2006-04-03 PE PE2006000359A patent/PE20061355A1/es not_active Application Discontinuation
- 2006-04-03 GE GEAP200610302A patent/GEP20105001B/en unknown
- 2006-04-03 KR KR1020077022636A patent/KR20070118103A/ko not_active Application Discontinuation
- 2006-04-03 AR ARP060101310A patent/AR054435A1/es not_active Application Discontinuation
- 2006-04-03 UA UAA200710985A patent/UA89397C2/ru unknown
- 2006-04-03 ZA ZA200708445A patent/ZA200708445B/xx unknown
- 2006-04-03 RU RU2007140986/15A patent/RU2413510C2/ru not_active IP Right Cessation
- 2006-04-03 JP JP2007511227A patent/JP5259181B2/ja not_active Expired - Fee Related
- 2006-04-03 TW TW095111740A patent/TWI391132B/zh not_active IP Right Cessation
- 2006-04-03 WO PCT/JP2006/307047 patent/WO2006107019A1/ja active Application Filing
- 2006-04-03 NZ NZ561677A patent/NZ561677A/en not_active IP Right Cessation
- 2006-04-03 AU AU2006231752A patent/AU2006231752B2/en not_active Ceased
-
2007
- 2007-09-18 IL IL186049A patent/IL186049A0/en unknown
- 2007-09-18 CR CR9385A patent/CR9385A/es unknown
- 2007-10-25 MA MA30311A patent/MA29677B1/fr unknown
- 2007-11-05 NO NO20075599A patent/NO20075599L/no not_active Application Discontinuation
-
2009
- 2009-04-24 CL CL2009000980A patent/CL2009000980A1/es unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018176109A1 (pt) | 2017-03-30 | 2018-10-04 | Penello Temporao Jose Eduardo | Composição mulivítamínica para aprimoramento da fluência verbal, dimimuição dos sintomas da ansiedade de performance e seu método de preparação |
Also Published As
Publication number | Publication date |
---|---|
IL186049A0 (en) | 2008-02-09 |
CL2009000980A1 (es) | 2009-08-14 |
UA89397C2 (ru) | 2010-01-25 |
KR20070118103A (ko) | 2007-12-13 |
NO20075599L (no) | 2007-12-19 |
GEP20105001B (en) | 2010-06-10 |
WO2006107019A1 (ja) | 2006-10-12 |
CN101189219A (zh) | 2008-05-28 |
AU2006231752B2 (en) | 2012-03-01 |
CR9385A (es) | 2007-12-07 |
MA29677B1 (fr) | 2008-08-01 |
MY142214A (en) | 2010-11-15 |
TW200719885A (en) | 2007-06-01 |
ZA200708445B (en) | 2009-03-25 |
CA2602267A1 (en) | 2006-10-12 |
JPWO2006107019A1 (ja) | 2008-09-25 |
PE20061355A1 (es) | 2007-01-15 |
RU2413510C2 (ru) | 2011-03-10 |
JP5259181B2 (ja) | 2013-08-07 |
TWI391132B (zh) | 2013-04-01 |
EP1867641A1 (en) | 2007-12-19 |
RU2007140986A (ru) | 2009-05-20 |
US20090042861A1 (en) | 2009-02-12 |
NZ561677A (en) | 2011-02-25 |
EP1867641A4 (en) | 2010-01-13 |
AR054435A1 (es) | 2007-06-27 |
AU2006231752A1 (en) | 2006-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0607684A2 (pt) | composição farmacêutica, método para prevenir ou tratar distúrbios de depressão ou ansiedade, e, uso de (s)-n-[2-(1,6,7,8-tetraidro-2h-indeno[5,4-b]furan-8-il)-eti l]-propionamida | |
BRPI0717219A2 (pt) | "composição imunogênica, método para tratar ou prevenir doença, e, uso de uma composição imunogênica." | |
BRPI0508051A (pt) | derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes | |
BRPI0519047A2 (pt) | mÉtodo para a produÇço de um agente de contraste marcador ou agente terapÊutico marcador, agentes de contraste marcadores e uso de agentes de contraste marcadores ou de agentes terapÊuticos marcadores | |
WO2004047830A3 (de) | Pharmazeutische zusammensetzung aus einem beta-3-adrenozeptor-agonisten und einem serotonin- und/oder norepinephrin-reuptake-inhibitor deren verwendung zur behandlung von blasenfunktionsstörungen | |
EA200601746A1 (ru) | Применение ротиготина для лечения и предупреждения синдрома "паркинсонизм-плюс" | |
BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
CY1110046T1 (el) | Γαβοξαδολη για τη θεραπεια της καταθλιψης και αλλων συναισθηματικων διαταραχων | |
MY148459A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression | |
BRPI0508254A (pt) | métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos | |
BRPI0718469A2 (pt) | Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto. | |
NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
BRPI0612005A2 (pt) | agente profilático ou terapêutico, composição oftalmológica, uso de selenoproteína p, e, método de prevenção/tratamento de uma doença corneal/conjuntival | |
BRPI0408491A (pt) | tratamento da doença de alzheimer | |
BR0210650A (pt) | Tablete, e, uso do mesmo | |
WO2009015369A3 (en) | Isophthalamide derivatives inhibiting beta-secretase activity | |
CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. | |
BR0201524A (pt) | Tratamento de combinação para ansiedade e depressão | |
BRPI0408889A (pt) | uso de clusterina para o tratamento e/ou prevenção de doenças neurológicas periféricas | |
RS50148B (sr) | Upotreba docetaksela za lečenje hepatoćelijskog karcinoma | |
BRPI0506631A (pt) | combinações de um agente antiemético, composição farmacêutica e usos das combinações | |
NO20033318L (no) | 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav | |
MX2009003974A (es) | N-(2-hidroxietil)-n-metil-4-(quinolin-8-il(1-(tiazol-4-ilmetil)pi peridin-4-ilideno)metil)benzamida, el proceso para su sintesis, asi como su uso para el tratamiento del dolor, la ansiedad y la depresion. | |
GT200800066A (es) | Derivados de 9-cloro-15-deoxiprostaglandina, procedimiento para su preparacion y su uso como medicamento. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2307 DE 24/03/2015. |